{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T22:51:56Z","timestamp":1782687116141,"version":"3.54.5"},"reference-count":28,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2017,2,27]]},"DOI":"10.3233\/cbm-161671","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T09:52:57Z","timestamp":1481622777000},"page":"209-214","source":"Crossref","is-referenced-by-count":42,"title":["Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma"],"prefix":"10.1177","volume":"18","author":[{"given":"Fan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Oncology, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi, Xinjiang, China"},{"name":"Department of Oncology, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi, Xinjiang, China"},{"name":"Department of Oncology, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Sheng","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Department of Oncology, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guo","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-E","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/CBM-161671_ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.3233\/CBM-161671_ref2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.27048","article-title":"Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees","volume":"60","author":"Chien","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.3233\/CBM-161671_ref3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/ijms17030280","article-title":"MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma","volume":"17","author":"Hayes","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.3233\/CBM-161671_ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mito.2014.06.004","article-title":"MicroRNA regulation of cancer metabolism: role in tumour suppression","volume":"19","author":"Tomasetti","year":"2014","journal-title":"Mitochondrion"},{"issue":"10","key":"10.3233\/CBM-161671_ref5","first-page":"837","article-title":"Hepatic microRNA orchestra: a new diagnostic, prognostic and theranostic tool for hepatocarcinogenesis","volume":"14","author":"Boye","year":"2014","journal-title":"Mini Rev Med Chem"},{"issue":"11","key":"10.3233\/CBM-161671_ref6","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1586\/14737140.8.11.1759","article-title":"MicroRNA-221 and -222 pathway controls melanoma progression","volume":"8","author":"Felicetti","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"issue":"Suppl 3","key":"10.3233\/CBM-161671_ref7","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jceh.2014.03.045","article-title":"Staging of hepatocellular carcinoma","volume":"4","author":"Duseja","year":"2014","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.3233\/CBM-161671_ref8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"10.3233\/CBM-161671_ref9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/1389557515666150324125353","article-title":"MicroRNAs Contribute to Hepatocellular Carcinoma","volume":"15","author":"Song","year":"2015","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"10.3233\/CBM-161671_ref10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/mutage\/ger055","article-title":"Role of variations within microRNA-binding sites in cancer","volume":"27","author":"Landi","year":"2012","journal-title":"Mutagenesis"},{"issue":"8","key":"10.3233\/CBM-161671_ref11","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.3390\/ijms150814475","article-title":"MicroRNAs, genomic instability and cancer","volume":"15","author":"Vincent","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.3233\/CBM-161671_ref12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2014.04.008","article-title":"MicroRNA expression profiling of thymic epithelial tumors","volume":"85","author":"Ganci","year":"2014","journal-title":"Lung Cancer"},{"issue":"16","key":"10.3233\/CBM-161671_ref13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cub.2014.06.043","article-title":"Aberrant regulation and function of microRNAs in cancer","volume":"24","author":"Adams","year":"2014","journal-title":"Curr Biol"},{"issue":"4","key":"10.3233\/CBM-161671_ref14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"10.3233\/CBM-161671_ref15","first-page":"190","volume-title":"Nature","author":"Png","year":"2011"},{"issue":"8","key":"10.3233\/CBM-161671_ref16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10529-012-0934-3","article-title":"Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells","volume":"34","author":"Bakhshandeh","year":"2012","journal-title":"Biotechnol Lett"},{"issue":"2","key":"10.3233\/CBM-161671_ref17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3892\/ijo.2010.857","article-title":"Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors","volume":"38","author":"Koelz","year":"2011","journal-title":"Int J Oncol"},{"issue":"17","key":"10.3233\/CBM-161671_ref18","first-page":"2685","article-title":"Regulation of p27Kip1 by miRNA 221\/222 in glioblastoma","volume":"8","author":"Lorimer","year":"2009","journal-title":"Cell Cycle"},{"issue":"3","key":"10.3233\/CBM-161671_ref19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12022-007-0023-7","article-title":"Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues","volume":"18","author":"Tetzlaff","year":"2007","journal-title":"Endocr Pathol"},{"issue":"7","key":"10.3233\/CBM-161671_ref20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cgt.2014.29","article-title":"Downregulation of miR-221\/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3","volume":"21","author":"Gan","year":"2014","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"10.3233\/CBM-161671_ref21","first-page":"221","article-title":"Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis","volume":"17","author":"Lv","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"7","key":"10.3233\/CBM-161671_ref22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.molonc.2015.03.013","article-title":"miRNA-221 and miRNA-222 induce apoptosis via the KIT\/AKT signalling pathway in gastrointestinal stromal tumours","volume":"9","author":"Ihle","year":"2015","journal-title":"Mol Oncol"},{"issue":"2","key":"10.3233\/CBM-161671_ref23","first-page":"2024","article-title":"MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth","volume":"8","author":"Xu","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.3233\/CBM-161671_ref24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0034-1367025","article-title":"Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers","volume":"122","author":"Acibucu","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.3233\/CBM-161671_ref25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.urolonc.2009.06.005","article-title":"MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL","volume":"28","author":"Lu","year":"2010","journal-title":"Urol Oncol"},{"key":"10.3233\/CBM-161671_ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2015.12.002","article-title":"Downregulation of miR-221 enhances the sensitivity of human oral squamous cell carcinoma cells to Adriamycin through upregulation of TIMP3 expression","volume":"77","author":"Chen","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.3233\/CBM-161671_ref27","doi-asserted-by":"crossref","first-page":"e0148821","DOI":"10.1371\/journal.pone.0148821","article-title":"miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog\/p38\/Nuclear Factor-kappaB Pathway","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/CBM-161671_ref28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biomaterials.2015.09.036","article-title":"Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon","volume":"74","author":"Lee","year":"2016","journal-title":"Biomaterials"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-161671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:30Z","timestamp":1777385310000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-161671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":28,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-161671","relation":{},"ISSN":["1574-0153","1875-8592"],"issn-type":[{"value":"1574-0153","type":"print"},{"value":"1875-8592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}